Willis Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History

Willis Investment Counsel’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-287,012	Closed	-$13.7M	–	108
2019 Q1	$13.7M	Buy	287,012 +35,454	+14%	+$1.77M	0.94%	50
2018 Q4	$13.1M	Sell	251,558 -51,651	-17%	-$2.78M	0.97%	47
2018 Q3	$18.8M	Buy	303,209 +134,802	+80%	+$8M	1.3%	35
2018 Q2	$9.32M	Buy	168,407 +41	+0%	+$2.21K	0.69%	66
2018 Q1	$10.6M	Sell	168,366 -8,498	-5%	-$547K	0.82%	54
2017 Q4	$10.8M	Sell	176,864 -1,449	-0.8%	-$90.6K	0.76%	59
2017 Q3	$11.4M	Buy	178,313 +4,502	+3%	+$263K	0.82%	58
2017 Q2	$9.69M	Buy	173,811 +29,201	+20%	+$1.59M	0.73%	63
2017 Q1	$7.86M	Sell	144,610 -7,520	-5%	-$412K	0.59%	66
2016 Q4	$8.89M	Buy	152,130 +19,801	+15%	+$1.08M	0.66%	62
2016 Q3	$7.13M	Buy	+132,329	New	+$8.5M	0.57%	72
2013 Q4	–	Sell	-147,180	Closed	-$6.58M	–	118
2013 Q3	$6.58M	Hold	147,180	–	–	0.75%	59
2013 Q2	$6.58M	Buy	+147,180	New	+$6.39M	0.75%	59

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Willis Investment Counsel's BMY Position: Q2 2019 in Review

Willis Investment Counsel sold out of Bristol-Myers Squibb (BMY) in Q2 2019, closing a stake of 287,012 shares — an estimated $13.7M sold.

Willis Investment Counsel first reported a position in BMY in Q2 2013 and held it in 13 quarters. The position peaked at $18.8M in Q3 2018. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

Willis Investment Counsel reported no remaining Bristol-Myers Squibb position as of Q2 2019 after selling out during the quarter.
Willis Investment Counsel sold 287,012 Bristol-Myers Squibb shares in Q2 2019, an estimated $13.7M.
Willis Investment Counsel first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 13 quarters.
Willis Investment Counsel's Bristol-Myers Squibb position peaked at $18.8M in Q3 2018.
1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on Willis Investment Counsel's 13F filing for Q2 2019, filed 14 Aug 2019.